83 related articles for article (PubMed ID: 15547752)
21. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
[TBL] [Abstract][Full Text] [Related]
22. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
23. Specific regulation of HSPs in human tumor cell lines by PSK.
Morino M; Tsuzuki T; Ishikawa Y; Shirakami T; Yoshimura M; Kiyosuke Y; Matsunaga K; Yoshikumi C; Saijo N
In Vivo; 1997; 11(3):261-4. PubMed ID: 9239521
[TBL] [Abstract][Full Text] [Related]
24. Antimetastatic effect of PSK, a protein-bound polysaccharide, against the B16-BL6 mouse melanoma.
Matsunaga K; Ohhara M; Oguchi Y; Iijima H; Kobayashi H
Invasion Metastasis; 1996; 16(1):27-38. PubMed ID: 8830763
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis.
Kim HS; Kang SH; Park CH; Yang WI; Jeung HC; Chung HC; Roh JK; Ahn JB; Kim NK; Min BS; Rha SY
Oncol Rep; 2011 Mar; 25(3):717-27. PubMed ID: 21206979
[TBL] [Abstract][Full Text] [Related]
26. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.
Jiménez-Medina E; Berruguilla E; Romero I; Algarra I; Collado A; Garrido F; Garcia-Lora A
BMC Cancer; 2008 Mar; 8():78. PubMed ID: 18366723
[TBL] [Abstract][Full Text] [Related]
27. Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
Mekata E; Murata S; Sonoda H; Shimizu T; Umeda T; Shiomi H; Naka S; Yamamoto H; Abe H; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tani T
Oncol Rep; 2013 Dec; 30(6):2845-51. PubMed ID: 24100378
[TBL] [Abstract][Full Text] [Related]
28. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
30. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
[TBL] [Abstract][Full Text] [Related]
34. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.
Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Danenberg PV; Shimada H
Int J Oncol; 2005 Aug; 27(2):371-6. PubMed ID: 16010417
[TBL] [Abstract][Full Text] [Related]
35. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters.
Ohwada S; Ogawa T; Makita F; Tanahashi Y; Ohya T; Tomizawa N; Satoh Y; Kobayashi I; Izumi M; Takeyoshi I; Hamada K; Minaguchi S; Togo Y; Toshihiko T; Koyama T; Kamio M
Oncol Rep; 2006 Apr; 15(4):861-8. PubMed ID: 16525672
[TBL] [Abstract][Full Text] [Related]
37. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
Ichikawa W; Ooyama A; Toda E; Sugimoto Y; Oka T; Takahashi T; Shimizu M; Sasaki Y; Hirayama R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):794-801. PubMed ID: 16528528
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of osteoprotegerin expression in human colorectal cancer.
Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
[TBL] [Abstract][Full Text] [Related]
39. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
Hockley SL; Arlt VM; Brewer D; Giddings I; Phillips DH
BMC Genomics; 2006 Oct; 7():260. PubMed ID: 17042939
[TBL] [Abstract][Full Text] [Related]
40. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives.
Maehara Y; Tsujitani S; Saeki H; Oki E; Yoshinaga K; Emi Y; Morita M; Kohnoe S; Kakeji Y; Yano T; Baba H
Surg Today; 2012 Jan; 42(1):8-28. PubMed ID: 22139128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
